Vivoryon Therapeutics Company
%20.jpg)
Vivoryon Therapeutics is a Germany based biopharmaceutical company engaged in the activities of research and development, preclinical and clinical trials. It is focused on the development of therapeutic products for the treatment of Alzheimer's disease and cancer. The company's pipeline products includes PQ912, PQ1565 and PQ-family.
Employee Number:
101-250
Total Funding:
$5M
Founded Date:
1-1
Last Funding Type:
Private Equity
Estimated Revenue:
$1M to $10M
Investors Number:
1
Funding Status:
IPO
Headquarters:
Halle An Der Saale, Sachsen-Anhalt, Germany
Investor Type:
For Profit
Industry:
Biotechnology, Health Care, Science and Engineering
Technology:
Geroscience